Literature DB >> 22286414

Discussion. Tamoxifen increases the risk of microvascular flap complications in patients undergoing microvascular breast reconstruction.

Joseph J Disa1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22286414     DOI： 10.1097/PRS.0b013e31823aeccd

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN： 0032-1052            Impact factor:   4.730


× No keyword cloud information.
  3 in total

1.  Systemic Therapy for Early-Stage Breast Cancer: What the Plastic Surgeon Should Know.

Authors:  Chad M Teven; Daniel B Schmid; Mark Sisco; James Ward; Michael A Howard
Journal:  Eplasty       Date:  2017-02-21

2.  Patient Management Strategies in Perioperative, Intraoperative, and Postoperative Period in Breast Reconstruction With DIEP-Flap: Clinical Recommendations.

Authors:  Kuo Chen; Narasimha M Beeraka; Mikhail Y Sinelnikov; Jin Zhang; Dajiang Song; Yuanting Gu; Jingruo Li; I V Reshetov; O I Startseva; Junqi Liu; Ruitai Fan; Pengwei Lu
Journal:  Front Surg       Date:  2022-02-15

3.  Is tamoxifen associated with an increased risk for thromboembolic complications in patients undergoing microvascular breast reconstruction?

Authors:  Andreas Jokuszies; Christine Radtke; Christopher Betzler; Ludwik Branski; Robert Krämer; Peter M Vogt
Journal:  Ger Med Sci       Date:  2013-02-18
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.